Cardiovascular Innovations and Applications journal (volume 2 issue 3) published

July 31, 2017

Beijing, 16 July, 2017: The new journal Cardiovascular Innovations and Applications (CVIA) has just published the third issue of Volume 2. This issue brings together a diverse set of papers from authors from China, Chile, Germany, Italy, Japan, and the United States.

Papers in this issue are:

REVIEWS

Maria Bergami, Peter Louis Amaduzzi and Raffaele Bugiardini
Takotsubo Syndrome: Does the Octopus Trap Hide Dangers? (http://ow.ly/qv6h30dOlld)

Edgardo Escobar and Carlos Akel
Telemedicine: It's Importance in Cardiology Practice. Experience in Chile (http://ow.ly/vL6e30dOlFn)

Amit Gupta, Melissa Dakkak and Alan Miller
Digoxin and Heart Failure: Are We Clear Yet? (http://ow.ly/Bskk30dOlPo)

Jagadeesh K. Kalavakunta, Mayank K. Mittal, Abed Janoudi, Oliver G. Abela, Fadi Alreefi and George S. Abela
Role of Cholesterol Crystals During Acute Myocardial Infarction and Cerebrovascular Accident (http://ow.ly/NhVb30dOlVS)

Eric I-Hun Jeng, David John Hall, Caleb Matthews, Eddie Ward Manning III and Thomas Mark Beaver
Infective Endocarditis: A Review of the Past and Present, and a Look into the Future (http://ow.ly/Vkbg30dOmbj)

Masahiro Kohzuki and Osamu Ito
Chronic Kidney Disease is a New Target of Cardiac Rehabilitation (http://ow.ly/U7ob30dOmrS)

ORIGINAL ARTICLES

Feng Liang, Xiuhua Ma, Liuzhuang Zhao, Chengwei Xing, Xin Li, Dongjing Zhao, Da-Yi Hu, Shuoqiang Hu, Wenbin Wang, Lantang Han, Shujun Cao, Huifang Liu and Zhengyu Bian
Evaluation of Multidisciplinary Collaborative Care in Patients with Acute Coronary Syndrome and Depression and/or Anxiety Disorders (http://ow.ly/JjF330dOmle)

Lili Wei, Datun Qi, Yong'en Shi, Chuanyu Gao and Weili Liu
Relationship Between Morning Hypertension and T-Peak to T-End Interval in Patients with Suspected Coronary Heart Disease (http://ow.ly/26Q830dRKUo)

COMMENTARIES

C. Richard Conti
Antibody Therapy of Hypercholesterolemia (http://ow.ly/yEMD30dOm4N)

Some thoughts about Impact Factor and Journal Editorials (http://ow.ly/GffU30dOmIE)
To TAVR or Not to TAVR (http://ow.ly/3lvk30dOmSx)

CASE REPORT

Giancarlo Pirozzolo, Anastasios Athanasiadis, Udo Sechtem and Peter Ong
Occlusive Spasm of the Left Anterior Descending Artery and First Diagonal Branch After Implantation of Everolimus Eluting Stents Without Re-stenosis in a Female Patient with Resting Angina (http://ow.ly/3L6V30dOmA0)
-end-
ABOUT THE JOURNAL

CVIA is available on the IngentaConnect platform and at http://cvia-journal.org/. Submissions may be made using ScholarOne Manuscripts (https://mc04.manuscriptcentral.com/cvia-journal). There are no author submission or article processing fees.

Cardiovascular Innovations and Applications

Related Acute Coronary Syndrome Articles from Brightsurf:

Effects of acute and chronic graft-versus-myelodysplastic syndrome on long-term outcomes following a
A research group led by Assistant Professor Takaaki Konuma in the Department of Hematology/Oncology, the Hospital of the Institute of Medical Science, the University of Tokyo (IMSUT Hospital) has demonstrated a graft-versus-tumor (GVT) effect of a previously unknown/novel allogeneic hematopoietic cell transplantation in MDS patients.

Effect of dexamethasone on days alive, ventilator-free in patients with COVID-19, acute respiratory distress syndrome
This randomized clinical trial in Brazil of 299 patients with COVID-19 and moderate or severe acute respiratory distress syndrome (ARDS) examined if intravenous dexamethasone plus standard care compared with standard care alone would increase the number of days patients were alive and free from mechanical ventilation.

UofSC researchers reveal how THC may treat acute respiratory distress syndrome
Acute Respiratory Distress Syndrome (ARDS), when caused by a bacterial toxin known as Staphylococcal enterotoxin, can be completely prevented by treatment with Δ9-tetrahydrocannabinol (THC), a cannabinoid found in the cannabis plant.

Fewer fungi types in lungs linked to worse disease in acute respiratory distress syndrome
Many COVID-19 patients develop acute respiratory distress syndrome (ARDS), a life-threatening condition where the lungs cannot provide the body's vital organs with enough oxygen.

Diagnosing acute aortic syndrome: New guideline for hard-to-diagnose condition
A new guideline aimed at helping clinicians identify the difficult-to-diagnose acute aortic syndrome is published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.200021.

Women taking beta blockers for hypertension may have higher risk of heart failure with acute coronary syndrome
Women have historically been underrepresented in past clinical research, raising concerns about their use of beta blockers as a treatment for hypertension.

Time to re-define sex-specific symptoms of acute coronary syndrome, say researchers
While there are differences between how women and men display in heart attack symptoms, researchers argue that continuing to simplify these symptoms as 'typical' or 'atypical' could contribute to delayed treatment and poorer health outcomes.

Does coronary microvascular spasm exist?
In a new publication from Cardiovascular Innovations and Applications; Fabian Guenther, Andreas Seitz, Valeria Martínez Pereyra, Raffi Bekeredjian, Udo Sechtem and Peter Ong from the Department of Cardiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany consider whether coronary microvascular spasm exists.

Research revises classification of acute myeloid leukemia & myelodysplastic syndrome
Findings presented as a late-breaking abstract at the American Society of Hematology annual meeting by St.

Selective coronary angiography following cardiac arrest
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Read More: Acute Coronary Syndrome News and Acute Coronary Syndrome Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.